An immuno-therapeutic platform technology – essentially a cytokine factory – that eradicates 100% of intraperitoneal tumors has been developed by researchers at Rice University and licensed exclusively to Avenge Bio, Inc. It appears to have the potential to dramatically improve prognosis for ovarian cancer patients. There is a caveat, however. These results have, so far, only been demonstrated in […]

A couple of months ago, Shoreline Biosciences Chairman and CEO Kleanthis Xanthopoulos, Ph.D. told me that the key to securing venture capital is found in your people. Fresh on the heels of securing a $140 million round of financing, he told me, “More than anything else, it’s about the quality of the people you bring […]

A Florida biotechnology company has now made itself at home in its $55 million Vandalia processing center, pursuing what company leaders believe are advancements in human tissue and nerve repair. “The entire project team is inside the new facility,” Todd Puckett, operations manager for the Axogen Corp. Industrial Park Drive site, said in a recent […]